AR108472A1 - METHODS OF TREATMENT OF THE DISORDERS OF THE CIRCADIAN RATE OF SLEEP - Google Patents

METHODS OF TREATMENT OF THE DISORDERS OF THE CIRCADIAN RATE OF SLEEP

Info

Publication number
AR108472A1
AR108472A1 ARP170101275A ARP170101275A AR108472A1 AR 108472 A1 AR108472 A1 AR 108472A1 AR P170101275 A ARP170101275 A AR P170101275A AR P170101275 A ARP170101275 A AR P170101275A AR 108472 A1 AR108472 A1 AR 108472A1
Authority
AR
Argentina
Prior art keywords
treatment
methods
sleep
circadian
disorders
Prior art date
Application number
ARP170101275A
Other languages
Spanish (es)
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of AR108472A1 publication Critical patent/AR108472A1/en

Links

Abstract

Métodos de tratamiento del trastorno del ritmo irregular de sueño-vigilia en sujetos y composiciones para usar en los mismos.Methods of treatment of irregular sleep-wake rhythm disorder in subjects and compositions for use therein.

ARP170101275A 2016-05-12 2017-05-12 METHODS OF TREATMENT OF THE DISORDERS OF THE CIRCADIAN RATE OF SLEEP AR108472A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662335599P 2016-05-12 2016-05-12

Publications (1)

Publication Number Publication Date
AR108472A1 true AR108472A1 (en) 2018-08-22

Family

ID=63346400

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170101275A AR108472A1 (en) 2016-05-12 2017-05-12 METHODS OF TREATMENT OF THE DISORDERS OF THE CIRCADIAN RATE OF SLEEP

Country Status (1)

Country Link
AR (1) AR108472A1 (en)

Similar Documents

Publication Publication Date Title
MX2018013663A (en) Methods of treating circadian rhythm sleep disorders.
PH12019501575A1 (en) ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFá1 INHIBITORS AND USE THEREOF
EA201790737A1 (en) COMBINED THERAPY
CL2017003006A1 (en) Methods of conditioning patients for treatment with T lymphocytes
PH12016501809A1 (en) Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
MX2022007989A (en) Compositions and methods for treating pterygium.
DOP2017000268A (en) METHODS AND KITS TO TREAT DEPRESSION
EA201790195A1 (en) METHODS OF TREATING CANCER WITH THE USE OF TIGIT INHIBITORS AND ANTI-CANCER AGENTS
CO7131353A2 (en) Treatment of circadian rhythm disorders
CL2015002807A1 (en) Combination therapy
AR101312A1 (en) COMBINATIONS OF BET INHIBITORS AND INHIBITORS OF TIROSINA QUINASA DE BRUTON
BR112017018964A2 (en) use of plinabulin and methods to treat brain tumor
UY35625A (en) TETRAHYDROCARBAZOL AND CARBAZOL CARBOXAMIDA COMPOUNDS REPLACED AS QUINASA INHIBITORS
IT201600084470A1 (en) Composition for use in the treatment of major depressive disorder
DK3442513T3 (en) USE OF CANNABIDIOLIC ACID IN THE TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED DISORDERS
ECSP16086247A (en) (S) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
CO2020001107A2 (en) Therapeutic modulators of the reverse mode of atp synthase
EA201991175A1 (en) THE USE OF INTERFERON-LAMBDA IN MEDICINE FOR THE TREATMENT OF FIBROSIS
MX2018002298A (en) Methods of using interleukin-10 for treating diseases and disorders.
ECSP16086232A (en) (R) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
EA201792560A1 (en) NANOPARTICLES FOR APPLICATION AS A THERAPEUTIC VACCINE
EA201991488A1 (en) POTASSIUM CHANNEL MODULATORS
MX2019003314A (en) Methods of treating tim-3 elevation.
AR108472A1 (en) METHODS OF TREATMENT OF THE DISORDERS OF THE CIRCADIAN RATE OF SLEEP
AR105142A1 (en) TREATMENT METHODS OF MULTIFORM GLIOBLASTOMA WITH T-CELL THERAPY

Legal Events

Date Code Title Description
FB Suspension of granting procedure